Ulinastatin in Inhalation Lung Injury

Summary

The purpose of this study is to evaluate the efficacy and effect of ulinastatin in inhalation lung injury patients.

Conditions

• Inhalation Injury

Interventions

DRUG

ulinastatin

Resolved 4 vials of drugs in 100ml physiological saline solution,intravenously infused for 1-2h,tid,for continuous 10days

DRUG

blank group

standard treatment

Sponsors & Collaborators

• Changhai Hospital

  collaborator OTHER

• Southwest Hospital, China

  collaborator OTHER

• General Hospital of Beijing PLA Military Region

  collaborator OTHER

• Chinese PLA General Hospital

  lead OTHER

Principal Investigators

• sheng zhiyong, MD · First Hospitals affiliated to the China PLA General Hospital

• Jia chiyu, MD · First Hospitals affiliated to the China PLA General Hospital

• Xia zhaofan, MD · Changhai Hospital

• Pang yizhi, MD · Southwest Hospital, China

• Chen tunhu, MD · General Hospital of Jinan PLA Military Region

• Zhu jinmin, MD · General Hospital of Beijing PLA Military Region

• Liu yi, MD · General Hospital of Lanzhou PLA Military Region

• Cui xiaolin, MD · Liaonin People's Armed Police Corps Hospital

• Sheng guanyu, MD · 187 Central Hospital of the Chinese PLA

• Lu qinjun, MD · 251 Central Hospital of the Chinese PLA

• Shi shengfu, MD · 322 Central Hospital of the Chinese PLA

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

70 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2011-02-28

Primary Completion

2012-12-31

Completion

2013-01-31

Countries

• China

Study Locations